F. Montastruc

First name
F.
Last name
Montastruc
Engler, J., Filliter, C., Montastruc, F., Abenhaim, H., Rej, S., & Renoux, C. (2024). Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors. J Affect Disord, 350, 813-821. http://doi.org/10.1016/j.jad.2024.01.163
Cao, T. X. D., Filliter, C., Montastruc, F., H. Y. Yu, O., Fergusson, E., Rej, S., et al. (2022). Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths. J Affect Disord, 318, 231-237. http://doi.org/10.1016/j.jad.2022.08.094
Khosrow-Khavar, F., Azoulay, L., Montastruc, J. L., Montastruc, F., & Renoux, C. (2022). Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study. Cancer. http://doi.org/10.1002/cncr.34208
Abrahami, D., Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., et al. (2018). Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k4880
Montastruc, F., Nie, R., Loo, S., Rej, S., Dell'Aniello, S., Micallef, J., et al. (2019). Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide. JAMA Psychiatry. http://doi.org/10.1001/jamapsychiatry.2018.4149
Rahman, A., Kane, J., Montastruc, F., & Renoux, C. (2021). Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14727